Brought to you by 
Amgen partners with Cytokinetics on heart failure drug
Jan 2007
Executive Summary
Amgen has teamed up with Cytokinetics (developing small-molecule therapeutics that focus on the cytoskeleton) to discover, develop, and market small-molecule heart failure pharmaceuticals globally, excluding Japan. The companies will create compounds that activate cardiac muscle contractility.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Intra-Biotech Deal
- R+D and Marketing-Licensing
- Includes Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com